Skip to main content

Published locations for FDA adds RA indication for Riabni rituximab biosimilar

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA adds RA indication for Riabni rituximab biosimilar

User login

  • Reset your password
  • /content/fda-adds-ra-indication-riabni-rituximab-biosimilar
  • /familypracticenews/article/255276/rheumatoid-arthritis/fda-adds-ra-indication-riabni-rituximab
  • /internalmedicinenews/article/255276/rheumatoid-arthritis/fda-adds-ra-indication-riabni-rituximab
  • /rheumatologynews/article/255276/rheumatoid-arthritis/fda-adds-ra-indication-riabni-rituximab
  • /rheumatology/article/255276/rheumatoid-arthritis/fda-adds-ra-indication-riabni-rituximab-biosimilar
  • /internalmedicine/article/255276/rheumatoid-arthritis/fda-adds-ra-indication-riabni-rituximab
  • /familymedicine/article/255276/rheumatoid-arthritis/fda-adds-ra-indication-riabni-rituximab